Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 24, which means every article in Journal of Vaccines & Vaccination has got 24 average citations.

Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

67 60 59 65 71 11 19 26 45 44 52 59 54 13 14

Research, Review articles and Editorials

14 14 19 41 29 11 15 16 17 34 40 42 38 10 10

Research communications, Review communications, Editorial communications, Case reports and Commentary

38 46 40 30 42 0 4 10 28 10 12 17 21 3 4

Conference proceedings

18 8 32 23 0 0 112 104 154 315 180 116 110 122 0

Citations received as per Google Scholar, other indexing platforms and portals

121 206 193 258 232 212 200 205 224 245 110 61 22 20 0
Journal total citations count 2341
Journal impact factor 2.87
Journal 5 years impact factor 3.73
Journal cite score 4.69
Journal h-index 24
Important citations

PREVALENCE OF HEPATITIS B VIRUS INFECTION IN HEALTH CARE WORKERS OF A TERTIARY CARE HOSPITAL

Novel Aspects and Strategies in Vaccination

Hexavalent vaccines: What can we learn from head-to-head studies?

Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP?T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea.

DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination.

DTaP-IPV-Hep B-Hib vaccine (Hexyon ® /Hexacima ® ): a guide to its use in the primary and booster vaccination of infants and toddlers in Europe

Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim) following primary series administration at 2, 4, 6 months of age in Latin America.

Hexavalent vaccines in infants: a systematic literature review and meta-analysis of the solicited local and systemic adverse reactions of two hexavalent vaccines.

Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP?T vaccination at 2, 4 and 6 months.

Hexavalent vaccines for immunization in paediatric age

Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.

New perspectives for hexavalent vaccines.

Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration.

DTaP-IPV-Hep B-Hib vaccine (Hexaxim®) : a review of its use in primary and booster vaccination.

Novel Aspects and Strategies in Vaccination

Development of Prophylactic Bivalent and Quadrivalent Human Papillomavirus (HPV) Vaccines: A Review

Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration

Novel Aspects and Strategies in Vaccination

Cytochrome B - Analysis of Hydrophobicity, Surface Accessibility,Antigenicity and Prediction of MHC I and MHC II Binders fromDracunculiasis

Novel Aspects and Strategies in Vaccination